{"hits":{"hits":[{"_source":{"title":"UBE2I imputed & refined","methodText":"##Scoring procedure:\r\nDMS-BarSeq and DMS-TileSeq reads were processed using the [dmsPipeline](https://bitbucket.org/rothlabto/dmspipeline) software. Briefly, Barseq read counts were used to establish relative frequencies of each strain at each timepoint and converted to estimates of absolute frequencies using OD measurement data. Absolute counts were used to establish growth curves from which fitness parameters were estimated and then normalized to 0-1 scale where 0 corresponds to null controls and 1 corresponds to WT controls. Meanwhile, TileSeq read counts were used to establish relative allele frequencies in each condition. Non-mutagenized control counts were subtracted from counts (as estimates of sequencing error). log ratios of selection over non-selection counts were calculated. The resulting TileSeq fitness values were then rescaled to the distribution of the BarSeq fitness scores. Fitness scores were joined using confidence-weighted averages. Random-Forest base machine learning was used to impute missing values and refine low-confidence measurements, based on intrinsic, structural, and biochemical features.\r\n\r\nSee [**Weile *et al.* 2017**](http://msb.embopress.org/content/13/12/957) for more details.\r\n\r\n## Additional columns:\r\n* exp.score = experimental score from the joint DMS-BarSeq/DMS-TileSeq screens\r\n* exp.sd = standard deviation of the experimental score\r\n* df = degrees of freedom (number of replicates contributing to the experimental score)\r\n* pred.score = machine-learning predicted score","abstractText":"Although we now routinely sequence human genomes, we can confidently identify only a fraction of the sequence variants that have a functional impact. Here, we developed a deep mutational scanning framework that produces exhaustive maps for human missense variants by combining random codon mutagenesis and multiplexed functional variation assays with computational imputation and refinement. We applied this framework to four proteins corresponding to six human genes: UBE2I (encoding SUMO E2 conjugase), SUMO1 (small ubiquitin-like modifier), TPK1 (thiamin pyrophosphokinase), and CALM1/2/3 (three genes encoding the protein calmodulin). The resulting maps recapitulate known protein features and confidently identify pathogenic variation. Assays potentially amenable to deep mutational scanning are already available for 57% of human disease genes, suggesting that DMS could ultimately map functional variation for all human disease genes. \r\n\r\nSee [**Weile *et al.* 2017**](http://msb.embopress.org/content/13/12/957)","shortDescription":"A joint Deep Mutational Scan of the human SUMO E2 conjugase UBE2I using functional complementation in yeast, combining DMS-BarSeq and DMS-TileSeq data, followed by machine-learning-based imputation and refinement.","urn":"urn:mavedb:00000001-a-1","numVariants":3180}},{"_source":{"title":"UBE2I DMS-BarSeq","methodText":"##Scoring procedure:\r\nDMS-BarSeq and reads were processed using the [dmsPipeline](https://bitbucket.org/rothlabto/dmspipeline) software. Briefly, Barseq read counts were used to establish relative frequencies of each strain at each timepoint and converted to estimates of absolute frequencies using OD measurement data. Absolute counts were used to establish growth curves from which fitness parameters were estimated and then normalized to 0-1 scale where 0 corresponds to null controls and 1 corresponds to WT controls. \r\n\r\nSee [**Weile *et al.* 2017**](http://msb.embopress.org/content/13/12/957) for more details.","abstractText":"Although we now routinely sequence human genomes, we can confidently identify only a fraction of the sequence variants that have a functional impact. Here, we developed a deep mutational scanning framework that produces exhaustive maps for human missense variants by combining random codon mutagenesis and multiplexed functional variation assays with computational imputation and refinement. We applied this framework to four proteins corresponding to six human genes: UBE2I (encoding SUMO E2 conjugase), SUMO1 (small ubiquitin-like modifier), TPK1 (thiamin pyrophosphokinase), and CALM1/2/3 (three genes encoding the protein calmodulin). The resulting maps recapitulate known protein features and confidently identify pathogenic variation. Assays potentially amenable to deep mutational scanning are already available for 57% of human disease genes, suggesting that DMS could ultimately map functional variation for all human disease genes. \r\n\r\nSee [**Weile *et al.* 2017**](http://msb.embopress.org/content/13/12/957)","shortDescription":"A Deep Mutational Scan of the human SUMO E2 conjugase UBE2I using functional complementation in yeast via DMS-BarSeq","urn":"urn:mavedb:00000001-a-2","numVariants":3418}},{"_source":{"title":"UBE2I DMS-TileSeq","methodText":"##Scoring procedure:\r\nDMS-TileSeq reads were processed using [tileseq_package](https://bitbucket.org/rothlabto/tileseq_package) and [dmsPipeline](https://bitbucket.org/rothlabto/dmspipeline) software. Briefly, TileSeq read counts were used to establish relative allele frequencies in each condition. Non-mutagenized control counts were subtracted from counts (as estimates of sequencing error). log ratios of selection over non-selection counts were calculated. The resulting TileSeq fitness values were normalized to a 0-1 scale, where 0 corresponds to the median nonsense variant score and 1 corresponds to the median synonymous score.\r\n\r\nSee [**Weile *et al.* 2017**](http://msb.embopress.org/content/13/12/957) for more details.","abstractText":"Although we now routinely sequence human genomes, we can confidently identify only a fraction of the sequence variants that have a functional impact. Here, we developed a deep mutational scanning framework that produces exhaustive maps for human missense variants by combining random codon mutagenesis and multiplexed functional variation assays with computational imputation and refinement. We applied this framework to four proteins corresponding to six human genes: UBE2I (encoding SUMO E2 conjugase), SUMO1 (small ubiquitin-like modifier), TPK1 (thiamin pyrophosphokinase), and CALM1/2/3 (three genes encoding the protein calmodulin). The resulting maps recapitulate known protein features and confidently identify pathogenic variation. Assays potentially amenable to deep mutational scanning are already available for 57% of human disease genes, suggesting that DMS could ultimately map functional variation for all human disease genes. \r\n\r\nSee [**Weile *et al.* 2017**](http://msb.embopress.org/content/13/12/957)","shortDescription":"A Deep Mutational Scan of the human SUMO E2 conjugase UBE2I using functional complementation in yeast via DMS-TileSeq.","urn":"urn:mavedb:00000001-a-3","numVariants":7390}},{"_source":{"title":"UBE2I joint data","methodText":"##Scoring procedure:\r\nDMS-BarSeq and DMS-TileSeq reads were processed using the [dmsPipeline](https://bitbucket.org/rothlabto/dmspipeline) software. Briefly, Barseq read counts were used to establish relative frequencies of each strain at each timepoint and converted to estimates of absolute frequencies using OD measurement data. Absolute counts were used to establish growth curves from which fitness parameters were estimated and then normalized to 0-1 scale where 0 corresponds to null controls and 1 corresponds to WT controls. Meanwhile, TileSeq read counts were used to establish relative allele frequencies in each condition. Non-mutagenized control counts were subtracted from counts (as estimates of sequencing error). log ratios of selection over non-selection counts were calculated. The resulting TileSeq fitness values were then rescaled to the distribution of the BarSeq fitness scores. Fitness scores were joined using confidence-weighted averages. \r\n\r\nSee [**Weile *et al.* 2017**](http://msb.embopress.org/content/13/12/957) for more details.","abstractText":"Although we now routinely sequence human genomes, we can confidently identify only a fraction of the sequence variants that have a functional impact. Here, we developed a deep mutational scanning framework that produces exhaustive maps for human missense variants by combining random codon mutagenesis and multiplexed functional variation assays with computational imputation and refinement. We applied this framework to four proteins corresponding to six human genes: UBE2I (encoding SUMO E2 conjugase), SUMO1 (small ubiquitin-like modifier), TPK1 (thiamin pyrophosphokinase), and CALM1/2/3 (three genes encoding the protein calmodulin). The resulting maps recapitulate known protein features and confidently identify pathogenic variation. Assays potentially amenable to deep mutational scanning are already available for 57% of human disease genes, suggesting that DMS could ultimately map functional variation for all human disease genes. \r\n\r\nSee [**Weile *et al.* 2017**](http://msb.embopress.org/content/13/12/957)","shortDescription":"A joint Deep Mutational Scan dataset of the human SUMO E2 conjugase UBE2I using functional complementation in yeast, combining DMS-BarSeq and DMS-TileSeq","urn":"urn:mavedb:00000001-a-4","numVariants":10438}},{"_source":{"title":"SUMO1 imputed and refined","methodText":"##Scoring procedure:\r\nDMS-TileSeq reads were processed using the [dmsPipeline](https://bitbucket.org/rothlabto/dmspipeline) software. Briefly, TileSeq read counts were used to establish relative allele frequencies in each condition. Non-mutagenized control counts were subtracted from counts (as estimates of sequencing error). log ratios of selection over non-selection counts were calculated. The resulting TileSeq fitness values were then normalized to 0-1 scale where 0 corresponds to the median nonsense score and 1 corresponds to the median synonymous score. Random-Forest-based machine learning was used to impute missing values and refine low-confidence measurements, based on intrinsic, structural, and biochemical features.\r\n\r\nSee [**Weile *et al.* 2017**](http://msb.embopress.org/content/13/12/957) for more details.\r\n\r\n## Additional columns:\r\n* exp.score = experimental score from the joint DMS-BarSeq/DMS-TileSeq screens\r\n* exp.sd = standard deviation of the experimental score\r\n* df = degrees of freedom (number of replicates contributing to the experimental score)\r\n* pred.score = machine-learning predicted score","abstractText":"Although we now routinely sequence human genomes, we can confidently identify only a fraction of the sequence variants that have a functional impact. Here, we developed a deep mutational scanning framework that produces exhaustive maps for human missense variants by combining random codon mutagenesis and multiplexed functional variation assays with computational imputation and refinement. We applied this framework to four proteins corresponding to six human genes: UBE2I (encoding SUMO E2 conjugase), SUMO1 (small ubiquitin-like modifier), TPK1 (thiamin pyrophosphokinase), and CALM1/2/3 (three genes encoding the protein calmodulin). The resulting maps recapitulate known protein features and confidently identify pathogenic variation. Assays potentially amenable to deep mutational scanning are already available for 57% of human disease genes, suggesting that DMS could ultimately map functional variation for all human disease genes. \r\n\r\nSee [**Weile *et al.* 2017**](http://msb.embopress.org/content/13/12/957)","shortDescription":"A machine-learning imputed and refined Deep Mutational Scan of the human SUMO1 using functional complementation in yeast.","urn":"urn:mavedb:00000001-b-1","numVariants":2020}},{"_source":{"title":"SUMO1 DMS-TileSeq","methodText":"##Scoring procedure:\r\nDMS-TileSeq reads were processed using the [dmsPipeline](https://bitbucket.org/rothlabto/dmspipeline) software. Briefly, TileSeq read counts were used to establish relative allele frequencies in each condition. Non-mutagenized control counts were subtracted from counts (as estimates of sequencing error). log ratios of selection over non-selection counts were calculated. The resulting TileSeq fitness values were then normalized to 0-1 scale where 0 corresponds to the median nonsense score and 1 corresponds to the median synonymous score.\r\n\r\nSee [**Weile *et al.* 2017**](http://msb.embopress.org/content/13/12/957) for more details.\r\n\r\n## Additional columns:\r\n* exp.score = experimental score from the joint DMS-BarSeq/DMS-TileSeq screens\r\n* exp.sd = standard deviation of the experimental score\r\n* df = degrees of freedom (number of replicates contributing to the experimental score)\r\n* pred.score = machine-learning predicted score","abstractText":"Although we now routinely sequence human genomes, we can confidently identify only a fraction of the sequence variants that have a functional impact. Here, we developed a deep mutational scanning framework that produces exhaustive maps for human missense variants by combining random codon mutagenesis and multiplexed functional variation assays with computational imputation and refinement. We applied this framework to four proteins corresponding to six human genes: UBE2I (encoding SUMO E2 conjugase), SUMO1 (small ubiquitin-like modifier), TPK1 (thiamin pyrophosphokinase), and CALM1/2/3 (three genes encoding the protein calmodulin). The resulting maps recapitulate known protein features and confidently identify pathogenic variation. Assays potentially amenable to deep mutational scanning are already available for 57% of human disease genes, suggesting that DMS could ultimately map functional variation for all human disease genes. \r\n\r\nSee [**Weile *et al.* 2017**](http://msb.embopress.org/content/13/12/957)","shortDescription":"A Deep Mutational Scan of the human SUMO1 using functional complementation in yeast via DMS-TileSeq","urn":"urn:mavedb:00000001-b-2","numVariants":4698}},{"_source":{"title":"Human Calmodulin DMS-TileSeq","methodText":"##Scoring procedure:\r\nDMS-TileSeq reads were processed using the [dmsPipeline](https://bitbucket.org/rothlabto/dmspipeline) software. Briefly, TileSeq read counts were used to establish relative allele frequencies in each condition. Non-mutagenized control counts were subtracted from counts (as estimates of sequencing error). log ratios of selection over non-selection counts were calculated. The resulting TileSeq fitness values were then normalized to 0-1 scale where 0 corresponds to the median nonsense score and 1 corresponds to the median synonymous score. \r\n\r\nSee [**Weile *et al.* 2017**](http://msb.embopress.org/content/13/12/957) for more details.","abstractText":"Although we now routinely sequence human genomes, we can confidently identify only a fraction of the sequence variants that have a functional impact. Here, we developed a deep mutational scanning framework that produces exhaustive maps for human missense variants by combining random codon mutagenesis and multiplexed functional variation assays with computational imputation and refinement. We applied this framework to four proteins corresponding to six human genes: UBE2I (encoding SUMO E2 conjugase), SUMO1 (small ubiquitin-like modifier), TPK1 (thiamin pyrophosphokinase), and CALM1/2/3 (three genes encoding the protein calmodulin). The resulting maps recapitulate known protein features and confidently identify pathogenic variation. Assays potentially amenable to deep mutational scanning are already available for 57% of human disease genes, suggesting that DMS could ultimately map functional variation for all human disease genes. \r\n\r\nSee [**Weile *et al.* 2017**](http://msb.embopress.org/content/13/12/957)","shortDescription":"A Deep Mutational Scan of human Calmodulin using functional complementation in yeast via DMS-TileSeq.","urn":"urn:mavedb:00000001-c-1","numVariants":5957}},{"_source":{"title":"Human Calmodulin imputed and refined","methodText":"##Scoring procedure:\r\nDMS-TileSeq reads were processed using the [dmsPipeline](https://bitbucket.org/rothlabto/dmspipeline) software. Briefly, TileSeq read counts were used to establish relative allele frequencies in each condition. Non-mutagenized control counts were subtracted from counts (as estimates of sequencing error). log ratios of selection over non-selection counts were calculated. The resulting TileSeq fitness values were then normalized to 0-1 scale where 0 corresponds to the median nonsense score and 1 corresponds to the median synonymous score. Random-Forest-based machine learning was used to impute missing values and refine low-confidence measurements, based on intrinsic, structural, and biochemical features.\r\n\r\nSee [**Weile *et al.* 2017**](http://msb.embopress.org/content/13/12/957) for more details.\r\n\r\n## Additional columns:\r\n* exp.score = experimental score from the joint DMS-BarSeq/DMS-TileSeq screens\r\n* exp.sd = standard deviation of the experimental score\r\n* df = degrees of freedom (number of replicates contributing to the experimental score)\r\n* pred.score = machine-learning predicted score","abstractText":"Although we now routinely sequence human genomes, we can confidently identify only a fraction of the sequence variants that have a functional impact. Here, we developed a deep mutational scanning framework that produces exhaustive maps for human missense variants by combining random codon mutagenesis and multiplexed functional variation assays with computational imputation and refinement. We applied this framework to four proteins corresponding to six human genes: UBE2I (encoding SUMO E2 conjugase), SUMO1 (small ubiquitin-like modifier), TPK1 (thiamin pyrophosphokinase), and CALM1/2/3 (three genes encoding the protein calmodulin). The resulting maps recapitulate known protein features and confidently identify pathogenic variation. Assays potentially amenable to deep mutational scanning are already available for 57% of human disease genes, suggesting that DMS could ultimately map functional variation for all human disease genes. \r\n\r\nSee [**Weile *et al.* 2017**](http://msb.embopress.org/content/13/12/957)","shortDescription":"A machine-learning imputed and refined Deep Mutational Scan of human Calmodulin using functional complementation in yeast.","urn":"urn:mavedb:00000001-c-2","numVariants":2980}},{"_source":{"title":"TPK1 imputed and refined","methodText":"##Scoring procedure:\r\nDMS-TileSeq reads were processed using the [dmsPipeline](https://bitbucket.org/rothlabto/dmspipeline) software. Briefly, TileSeq read counts were used to establish relative allele frequencies in each condition. Non-mutagenized control counts were subtracted from counts (as estimates of sequencing error). log ratios of selection over non-selection counts were calculated. The resulting TileSeq fitness values were then normalized to 0-1 scale where 0 corresponds to the median nonsense score and 1 corresponds to the median synonymous score. Random-Forest-based machine learning was used to impute missing values and refine low-confidence measurements, based on intrinsic, structural, and biochemical features.\r\n\r\nSee [**Weile *et al.* 2017**](http://msb.embopress.org/content/13/12/957) for more details.\r\n\r\n## Additional columns:\r\n* exp.score = experimental score from the joint DMS-BarSeq/DMS-TileSeq screens\r\n* exp.sd = standard deviation of the experimental score\r\n* df = degrees of freedom (number of replicates contributing to the experimental score)\r\n* pred.score = machine-learning predicted score","abstractText":"Although we now routinely sequence human genomes, we can confidently identify only a fraction of the sequence variants that have a functional impact. Here, we developed a deep mutational scanning framework that produces exhaustive maps for human missense variants by combining random codon mutagenesis and multiplexed functional variation assays with computational imputation and refinement. We applied this framework to four proteins corresponding to six human genes: UBE2I (encoding SUMO E2 conjugase), SUMO1 (small ubiquitin-like modifier), TPK1 (thiamin pyrophosphokinase), and CALM1/2/3 (three genes encoding the protein calmodulin). The resulting maps recapitulate known protein features and confidently identify pathogenic variation. Assays potentially amenable to deep mutational scanning are already available for 57% of human disease genes, suggesting that DMS could ultimately map functional variation for all human disease genes. \r\n\r\nSee [**Weile *et al.* 2017**](http://msb.embopress.org/content/13/12/957)","shortDescription":"A machine-learning imputed and refined Deep Mutational Scan of human TPK1 using functional complementation in yeast.","urn":"urn:mavedb:00000001-d-2","numVariants":4860}},{"_source":{"title":"TPK1 DMS-TileSeq","methodText":"##Scoring procedure:\r\nDMS-TileSeq reads were processed using the [dmsPipeline](https://bitbucket.org/rothlabto/dmspipeline) software. Briefly, TileSeq read counts were used to establish relative allele frequencies in each condition. Non-mutagenized control counts were subtracted from counts (as estimates of sequencing error). log ratios of selection over non-selection counts were calculated. The resulting TileSeq fitness values were then normalized to 0-1 scale where 0 corresponds to the median nonsense score and 1 corresponds to the median synonymous score. \r\n\r\nSee [**Weile *et al.* 2017**](http://msb.embopress.org/content/13/12/957) for more details.","abstractText":"Although we now routinely sequence human genomes, we can confidently identify only a fraction of the sequence variants that have a functional impact. Here, we developed a deep mutational scanning framework that produces exhaustive maps for human missense variants by combining random codon mutagenesis and multiplexed functional variation assays with computational imputation and refinement. We applied this framework to four proteins corresponding to six human genes: UBE2I (encoding SUMO E2 conjugase), SUMO1 (small ubiquitin-like modifier), TPK1 (thiamin pyrophosphokinase), and CALM1/2/3 (three genes encoding the protein calmodulin). The resulting maps recapitulate known protein features and confidently identify pathogenic variation. Assays potentially amenable to deep mutational scanning are already available for 57% of human disease genes, suggesting that DMS could ultimately map functional variation for all human disease genes. \r\n\r\nSee [**Weile *et al.* 2017**](http://msb.embopress.org/content/13/12/957)","shortDescription":"A Deep Mutational Scan of human TPK1 using functional complementation in yeast via DMS-TileSeq.","urn":"urn:mavedb:00000001-d-1","numVariants":9542}}]}}
